PROTAC compounds targeting estrogen receptors, methods for their preparation, and use.

JP2026519066A5Pending Publication Date: 2026-07-17BEIJING SHENOGEN PHARMA GRP
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
BEIJING SHENOGEN PHARMA GRP
Filing Date
2024-05-26
Publication Date
2026-07-17

Smart Images

  • Figure 2024245169000001
    Figure 2024245169000001
  • Figure 2024245169000002
    Figure 2024245169000002
  • Figure 2024245169000003
    Figure 2024245169000003
Patent Text Reader

Abstract

This invention provides a PROTAC compound that targets the hydrolysis of estrogen receptor (ER) protein and its use.
Need to check novelty before this filing date? Find Prior Art